These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 24872082)

  • 1. Anti-apoptotic therapeutic approaches in liver diseases: do they really make sense?
    Bannert K; Kuhla A; Abshagen K; Vollmar B
    Apoptosis; 2014 Aug; 19(8):1243-53. PubMed ID: 24872082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant human erythropoietin attenuates hepatic injury induced by ischemia/reperfusion in an isolated mouse liver model.
    Hochhauser E; Pappo O; Ribakovsky E; Ravid A; Kurtzwald E; Cheporko Y; Lelchuk S; Ben-Ari Z
    Apoptosis; 2008 Jan; 13(1):77-86. PubMed ID: 18085440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cathepsin B inactivation attenuates the apoptotic injury induced by ischemia/reperfusion of mouse liver.
    Ben-Ari Z; Mor E; Azarov D; Sulkes J; Tor R; Cheporko Y; Hochhauser E; Pappo O
    Apoptosis; 2005 Dec; 10(6):1261-9. PubMed ID: 16215674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-apoptotic pro-survival effect of clotrimazole in a normothermic ischemia reperfusion injury animal model.
    Iannelli A; de Sousa G; Zucchini N; Saint-Paul MC; Gugenheim J; Rahmani R
    J Surg Res; 2011 Nov; 171(1):101-7. PubMed ID: 20605610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cleavage of poly (ADP-ribose) polymerase-1 is involved in the process of porcine ovarian follicular atresia.
    Wei Q; Shi F
    Anim Reprod Sci; 2013 May; 138(3-4):282-91. PubMed ID: 23522430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of PJ-34 PARP-inhibitor on rat liver microcirculation and antioxidant status.
    Szijártó A; Batmunkh E; Hahn O; Mihály Z; Kreiss A; Kiss A; Lotz G; Schaff Z; Váli L; Blázovics A; Geró D; Szabó C; Kupcsulik P
    J Surg Res; 2007 Sep; 142(1):72-80. PubMed ID: 17612561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of adenosine A2A receptor agonist (CGS) on ischemia/reperfusion injury in isolated rat liver.
    Ben-Ari Z; Pappo O; Sulkes J; Cheporko Y; Vidne BA; Hochhauser E
    Apoptosis; 2005 Oct; 10(5):955-62. PubMed ID: 16151631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pan-caspase inhibitor VX-166 reduces fibrosis in an animal model of nonalcoholic steatohepatitis.
    Witek RP; Stone WC; Karaca FG; Syn WK; Pereira TA; Agboola KM; Omenetti A; Jung Y; Teaberry V; Choi SS; Guy CD; Pollard J; Charlton P; Diehl AM
    Hepatology; 2009 Nov; 50(5):1421-30. PubMed ID: 19676126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5-Aminoisoquinolinone, a novel inhibitor of poly(adenosine disphosphate-ribose) polymerase, reduces microvascular liver injury but not mortality rate after hepatic ischemia-reperfusion.
    Khandoga A; Biberthaler P; Enders G; Krombach F
    Crit Care Med; 2004 Feb; 32(2):472-7. PubMed ID: 14758166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Caspase-8 and caspase-3 small interfering RNA decreases ischemia/reperfusion injury to the liver in mice.
    Contreras JL; Vilatoba M; Eckstein C; Bilbao G; Anthony Thompson J; Eckhoff DE
    Surgery; 2004 Aug; 136(2):390-400. PubMed ID: 15300206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual effect of erythropoietin on liver protection and regeneration after subtotal hepatectomy in rats.
    Greif F; Ben-Ari Z; Taya R; Pappo O; Kurtzwald E; Cheporko Y; Ravid A; Hochhauser E
    Liver Transpl; 2010 May; 16(5):631-8. PubMed ID: 20440772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Propofol protects hepatic L02 cells from hydrogen peroxide-induced apoptosis via activation of extracellular signal-regulated kinases pathway.
    Wang H; Xue Z; Wang Q; Feng X; Shen Z
    Anesth Analg; 2008 Aug; 107(2):534-40. PubMed ID: 18633031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ischemic preconditioning protects the mouse liver by inhibition of apoptosis through a caspase-dependent pathway.
    Yadav SS; Sindram D; Perry DK; Clavien PA
    Hepatology; 1999 Nov; 30(5):1223-31. PubMed ID: 10534344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CHOP deficiency attenuates cholestasis-induced liver fibrosis by reduction of hepatocyte injury.
    Tamaki N; Hatano E; Taura K; Tada M; Kodama Y; Nitta T; Iwaisako K; Seo S; Nakajima A; Ikai I; Uemoto S
    Am J Physiol Gastrointest Liver Physiol; 2008 Feb; 294(2):G498-505. PubMed ID: 18174271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Poly(ADP-ribose) polymerase inhibitors attenuate necrotic but not apoptotic neuronal death in experimental models of cerebral ischemia.
    Moroni F; Meli E; Peruginelli F; Chiarugi A; Cozzi A; Picca R; Romagnoli P; Pellicciari R; Pellegrini-Giampietro DE
    Cell Death Differ; 2001 Sep; 8(9):921-32. PubMed ID: 11526447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ambroxol alleviates hepatic ischemia reperfusion injury by antioxidant and antiapoptotic pathways.
    Jiang K; Wang X; Mao X; Lao H; Zhang J; Wang G; Cao Y; Tong I; Zhang F
    Transplant Proc; 2013; 45(6):2439-45. PubMed ID: 23953561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ischemic brain injury is mediated by the activation of poly(ADP-ribose)polymerase.
    Endres M; Wang ZQ; Namura S; Waeber C; Moskowitz MA
    J Cereb Blood Flow Metab; 1997 Nov; 17(11):1143-51. PubMed ID: 9390645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dieldrin promotes proteolytic cleavage of poly(ADP-ribose) polymerase and apoptosis in dopaminergic cells: protective effect of mitochondrial anti-apoptotic protein Bcl-2.
    Kitazawa M; Anantharam V; Kanthasamy A; Kanthasamy AG
    Neurotoxicology; 2004 Jun; 25(4):589-98. PubMed ID: 15183012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methotrexate induces poly(ADP-ribose) polymerase-dependent, caspase 3-independent apoptosis in subsets of proliferating CD4+ T cells.
    Nielsen CH; Albertsen L; Bendtzen K; Baslund B
    Clin Exp Immunol; 2007 May; 148(2):288-95. PubMed ID: 17286800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. First-in-class pan caspase inhibitor developed for the treatment of liver disease.
    Linton SD; Aja T; Armstrong RA; Bai X; Chen LS; Chen N; Ching B; Contreras P; Diaz JL; Fisher CD; Fritz LC; Gladstone P; Groessl T; Gu X; Herrmann J; Hirakawa BP; Hoglen NC; Jahangiri KG; Kalish VJ; Karanewsky DS; Kodandapani L; Krebs J; McQuiston J; Meduna SP; Nalley K; Robinson ED; Sayers RO; Sebring K; Spada AP; Ternansky RJ; Tomaselli KJ; Ullman BR; Valentino KL; Weeks S; Winn D; Wu JC; Yeo P; Zhang CZ
    J Med Chem; 2005 Nov; 48(22):6779-82. PubMed ID: 16250635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.